DUOS TECHNOLOGIES GROUP, INC. current report, 23 September 2017

Business Context and Reporting Period

Company: Duos Technologies Group, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 22, 2017 (Event Date: November 24, 2017)
Context: The Company entered into a Securities Purchase Agreement and Registration Rights Agreement with 55 investors to raise capital through a private offering. The transaction involved the issuance of common stock, warrants, and Series B Preferred Stock, alongside the conversion of existing liabilities and redemption of Series A Preferred Stock.

Key Financial Metrics and Transaction Details

Capital Raised: $11,031,371 (aggregate value of SPA Securities, including liability conversions and redemptions).
Securities Issued to Purchasers:

  • 16,402,742 shares of common stock.
  • 22,068,742 Purchaser Warrants (Strike Price: $0.65; Expiration: 5 years).
  • 2,830 shares of Series B Preferred Stock.
Issuance Pricing:
  • Class A Unit: $0.50 per share.
  • Class B Unit: $1,000 per share.
Debt and Liability Conversions:
  • JMJ Financial: Converted $2,105,263 of liabilities into 4,210,526 shares of common stock ($0.50/share) plus warrants.
  • Other Debt/Preferred Holders: Converted/repaid $3,003,189 into 6,006,378 shares of common stock ($0.50/share) plus warrants.
  • Executive Compensation: CEO converted $700,543 accrued salary; CFO converted $34,020 liabilities; Non-related entity converted $118,875 liabilities. All at $1.00/share plus warrants.
Placement Agent Compensation: Issued 2,206,274 warrants (Strike: $0.65) and 120,000 warrants (Strike: $1.00) to Joseph Gunnar & Co., LLC.
Post-Transaction Capitalization:
  • Common Stock Outstanding: 20,651,371 shares.
  • Series B Preferred Stock Outstanding: 2,830 shares.
  • Warrants Outstanding: 25,122,454.
Liquidity and Debt: The filing does not provide specific cash flow, total debt, or liquidity metrics outside of the specific liabilities converted in this transaction.

Material Changes Versus Prior Period

Capital Structure: Significant dilution occurred through the issuance of over 16 million new common shares and the conversion of approximately $5.1 million in liabilities and preferred stock into equity.
Corporate Governance: Mr. John E. Giles resigned from the Board of Directors and all committee positions effective November 28, 2017. The resignation was not due to any disagreement with the Company.
Equity Rights: The Company amended its Certificate of Incorporation to establish Series B Preferred Stock, which ranks senior to Common Stock and votes on an "as converted" basis.

Guidance, Outlook, Risks, and Unusual Items

Registration Rights: The Company must file a Registration Statement with the SEC covering the resale of SPA Securities and Placement Agent Warrants. The statement must be declared effective by January 13, 2018 (or February 12, 2018 if under full review).
Lock-Up Agreements: JMJ Financial and the Debt/Preferred Holders entered into 365-day lock-up agreements prohibiting the sale or transfer of their securities.
Future Participation: Purchasers have the right to participate in up to 35% of any subsequent offering of the Company's securities on the 24-month anniversary of the Private Offering.
Risks/Contingencies: The filing notes that the descriptions of agreements are subject to the full text of the exhibits. No specific forward-looking guidance on revenue or earnings was provided in this report.

Important Facts for Investor Verification

  • Valuation: Verify the implied valuation of the company based on the $0.50 per share issuance price for the majority of the offering.
  • Dilution Impact: Assess the impact of the 16.4 million new shares and 22 million new warrants on existing shareholder ownership.
  • Debt Relief: Confirm the total amount of debt and accrued liabilities removed from the balance sheet via conversion ($5.1 million+).
  • Registration Timeline: Monitor the SEC filing status to ensure the Registration Statement is declared effective by the January 13, 2018 deadline.
  • Executive Compensation: Review the conversion of $700,543 of CEO accrued salary into equity and warrants as a material compensatory arrangement.